Page last updated: 2024-11-07

prednisone and Anti-N-Methyl-D-Aspartate Receptor Encephalitis

prednisone has been researched along with Anti-N-Methyl-D-Aspartate Receptor Encephalitis in 7 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis: Disorder characterized by symptoms of CATATONIA; HYPOVENTILATION; DYSKINESIAS; ENCEPHALITIS; and SEIZURES followed by a reduced CONSCIOUSNESS. It is often followed by a viral-like prodrome. Many cases are self-limiting and respond well to IMMUNOMODULATORY THERAPIES against the NMDA RECEPTORS antibodies.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Zhang, J1
Gan, J1
Wang, J1
Li, R1
Jiang, L1
Li, XJ1
Hong, SQ1
Zhong, M1
Hu, Y1
Cantarín-Extremera, V1
Duat-Rodríguez, A1
González-Gutiérrez-Solana, L1
López-Marín, L1
Armangue, T1
Freeman, JW1
Freri, E1
Matricardi, S1
Patrini, M1
Binelli, S1
Andreetta, F1
Teutonico, F1
Nardocci, N1
Granata, T1
Shahani, L1
Bravo-Oro, A1
Acosta-Yebra, D1
Grimaldo-Zapata, IP1
Reyes-Vaca, G1

Reviews

1 review available for prednisone and Anti-N-Methyl-D-Aspartate Receptor Encephalitis

ArticleYear
[Reversible cortical atrophy secondary to anti-NMDA receptor antibody encephalitis].
    Revista de neurologia, 2015, May-16, Volume: 60, Issue:10

    Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Anticonvulsants; Aphasia, Broca; Aspartic Acid; Atr

2015

Other Studies

6 other studies available for prednisone and Anti-N-Methyl-D-Aspartate Receptor Encephalitis

ArticleYear
A case of GFAP-IgG positivity followed by anti-NMDAR encephalitis.
    BMC pediatrics, 2022, 10-17, Volume: 22, Issue:1

    Topics: Acyclovir; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Autoantibodies

2022
Analysis and discussion of the rare complication of autoimmune encephalitis: Two case reports.
    Medicine, 2018, Volume: 97, Issue:27

    Topics: Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Child; Encephalitis; Fatal Outcome; Female; Glucoco

2018
Clinical case of anti-N-methyl-D-aspartate receptor encephalitis in an 8-month-old patient with hyperkinetic movement disorder.
    Pediatric neurology, 2013, Volume: 48, Issue:5

    Topics: Anti-Dyskinesia Agents; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; D

2013
Extenuating circumstances anti-NMDA receptor encephalitis: a cautionary tale for neurology, psychiatry and the rest of us.
    South Dakota medicine : the journal of the South Dakota State Medical Association, 2014, Volume: 67, Issue:11

    Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antibodies, Monoclonal, Murine-Derived; Gluc

2014
Focal seizure, focal dyskinesia, or both? A complex motor phenomenon reveals anti-NMDAR encephalitis.
    Seizure, 2015, Volume: 27

    Topics: Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Child; Dyskinesias; Elect

2015
Steroid unresponsive anti-NMDA receptor encephalitis during pregnancy successfully treated with plasmapheresis.
    BMJ case reports, 2015, Apr-29, Volume: 2015

    Topics: Adult; Anti-Inflammatory Agents; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Female; Humans; Me

2015